Literature DB >> 1542108

T4 endonuclease VII resolves cruciform DNA with nick and counter-nick and its activity is directed by local nucleotide sequence.

S Pottmeyer1, B Kemper.   

Abstract

Endonuclease VII of phage T4 resolves Holliday structures in vitro by nicking pairs of strands across the junction. We report here analyses of this reaction between endonuclease VII and a Holliday structure analogue, made in vitro from synthetic oligonucleotides. The enzyme cleaves the structure in a non-concerted way and nicks each strand independently. Combinations of nicks with counter-nicks in strands across the junction resolve the construct. The specificity of the enzyme for DNA secondary structures was tested with a series of branched molecules made from oligonucleotides with the same nucleotide sequence in one strand. Results show that the number, location and relative cleavage efficiencies depend largely on the local nucleotide sequence, rather than on the branch type. In particular, endonuclease VII cleaves a complete four-armed cruciform as efficiently as a three-armed Y-junction or its derivatives, a semi-Y, a fork with two single-strand overhangs, a single-strand overhang, and a nicked DNA. However, exchange or addition of one or more nucleotides within the cleavage area flanking the structural signal for endonuclease VII strongly affects the cleavage pattern as well as their relative efficiency of usage. Examples with a single-stranded overhang are presented and show in summary that the enzyme has a fivefold preference for pyrimidines rather than purines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542108     DOI: 10.1016/0022-2836(92)90977-r

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes.

Authors:  George Hong; Kenneth N Kreuzer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

2.  Identification of a single HNH active site in type IIS restriction endonuclease Eco31I.

Authors:  Arturas Jakubauskas; Jolanta Giedriene; Janusz M Bujnicki; Arvydas Janulaitis
Journal:  J Mol Biol       Date:  2007-05-04       Impact factor: 5.469

3.  Endonuclease VII has two DNA-binding sites each composed from one N- and one C-terminus provided by different subunits of the protein dimer.

Authors:  R P Birkenbihl; B Kemper
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

4.  Dynamics of the T4 bacteriophage DNA packasome motor: endonuclease VII resolvase release of arrested Y-DNA substrates.

Authors:  Aparna Dixit; Krishanu Ray; Joseph R Lakowicz; Lindsay W Black
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

5.  Near-simultaneous DNA cleavage by the subunits of the junction-resolving enzyme T4 endonuclease VII.

Authors:  M J Giraud-Panis; D M Lilley
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

6.  The RuvC protein dimer resolves Holliday junctions by a dual incision mechanism that involves base-specific contacts.

Authors:  R Shah; R Cosstick; S C West
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

7.  The structure of the initiation complex at the replication origin, oriC, of Escherichia coli.

Authors:  B Woelker; W Messer
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

8.  Improved strategy for mutation detection--a modification to the enzyme mismatch cleavage method.

Authors:  J J Babon; R Youil; R G Cotton
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

9.  Resolution of Holliday junctions by eukaryotic DNA topoisomerase I.

Authors:  J Sekiguchi; N C Seeman; S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

10.  Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII.

Authors:  R Youil; B W Kemper; R G Cotton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.